Skip to main content
[Preprint]. 2023 Oct 25:2023.10.25.23297530. [Version 1] doi: 10.1101/2023.10.25.23297530

Table 5.

Adjusted Multinomial Logistic Regression Models Testing the Association between Demographics, Underlying Health Conditions, and COVID-Related Characteristics with Disease Severity

Moderate1 Severe1 Death1
Variable aOR2 95% CI2 p aOR2 95% CI2 p aOR2 95% CI2 p

Demographics
Age 1.05 1.03, 1.06 <0.001 1.05 1.03, 1.07 <0.001 1.09 1.05, 1.13 <0.001
Male 1.28 0.89, 1.85 0.18 1.34 0.82, 2.19 0.24 1.21 0.52, 2.81 0.66
White 0.70 0.46, 1.06 0.09 0.89 0.51, 1.54 0.67 0.73 0.27, 1.96 0.53
Underlying Conditions
Chronic Lung Disease 2.10 1.38, 3.17 <0.001 1.98 1.15, 3.41 0.01 1.31 0.50, 3.46 0.58
Hypertension 1.02 0.65, 1.59 0.94 0.97 0.53, 1.76 0.91 3.46 0.88, 13.57 0.08
Overweight 1.40 0.95, 2.07 0.09 1.17 0.69, 1.99 0.56 1.61 0.65, 4.01 0.30
Cardiovascular Disease 1.63 1.06, 2.50 0.03 1.45 0.82, 2.55 0.20 1.08 0.44, 2.63 0.87
Diabetes 0.99 0.64, 1.54 0.98 1.45 0.83, 2.54 0.20 1.09 0.43, 2.74 0.86
Renal Disease 2.64 1.61, 4.32 <0.001 1.91 1.01, 3.64 0.05 3.63 1.41, 9.36 0.01
Liver Disease 1.13 0.48, 2.69 0.78 1.84 0.69, 4.92 0.22 1.48 0.25, 8.78 0.67
Autoimmune Disease 1.78 0.87, 3.65 0.11 1.95 0.77, 4.95 0.16 3.96 1.00, 15.65 0.05
Immunocompromised3 1.08 0.55, 2.11 0.82 0.59 0.25, 1.40 0.23 3.26 0.83, 12.71 0.09
Systemic Immunosuppressive Therapy or Meds. 3.45 1.88, 6.32 <0.001 5.01 2.38, 10.51 <0.001 1.48 0.38, 5.71 0.57
Days Since Most Recent Vaccination/Booster
Unvaccinated Ref Ref Ref
Within past 90 Days 4 0.37 0.16, 0.88 0.02 0.40 0.13, 1.26 0.12 0.72 0.18, 2.86 0.64
91 – 180 Days Ago 4 0.32 0.19, 0.54 <0.001 0.42 0.21, 0.82 0.01 0.31 0.10, 0.96 0.04
181 – 270 Days Ago 4 0.32 0.18, 0.56 <0.001 0.38 0.17, 0.80 0.01 0.14 0.04, 0.59 0.01
More than 270 Days4 Ago 0.53 0.23, 1.21 0.13 0.88 0.34, 2.29 0.79 0.34 0.06, 1.95 0.23
Lineage
Delta Ref Ref Ref
Omicron5 0.95 0.61, 1.47 0.81 1.42 0.81, 2.50 0.22 2.07 0.84, 5.12 0.12
1

”Mild” is the Reference Category

2

aOR = Adjusted Odds Ratio, CI = Confidence Interval, Ref = Reference Level

3

HIV infection, active cancer, solid organ transplant, hematopoietic stem cell transplant

4

Compared to unvaccinated individuals

5

Compared to Delta